China SXT Pharmaceuticals, Inc. (SXTC) NASDAQ
2.01
+0.0826(+4.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.01
+0.0826(+4.29%)
Currency In USD
| Market Cap | 151.17M |
| Enterprise Value | 134.05M |
| P/E Ratio | -1.96 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.71 |
| Price/Book Ratio | 0.24 |
| Enterprise/Revenue | -20.2 |
| Enterprise/EBITDA | 9.08 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -2.74 |
| Operating Margin | -2.24 |
| Return On Assets | -0.09 |
| Return On Equity | -0.15 |
| Revenue | 1.74M |
| Revenue/Share | 0.37 |
| Gross Profit | 367,427 |
| EBITDA | -2.57M |
| Net Income | -3.3M |
| Diluted EPS | -8.18 |
| Total Cash | 21.17M |
| Total Cash/Share | 8.67 |
| Total Debt | 1.2M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.37 |
| Book Value Per Share | 8.28 |
| 52-Week Change | -98.69 |
| 52-Week High | 1,047 |
| 52-Week Low | 1.25 |
| Moving Average 50 Days | 2.07 |
| Moving Average 200 Days | 154.87 |
| Average Volume | 273,933 |
| Shares Outstanding | 773,532 |
| % Held by Institutions | 0.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:150 |
| Last Split Date | February 03, 2026 |